🇺🇸 FDA

Company profile · Sponsor

CellSeed

CellSeed Europe Ltd

E4175F1 · EMA pharma GB
Pipeline
1
Drugs
0
Patents
0

Quick answer

CellSeed (E4175F1) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E4175F1
Exchange EMA
Company type pharma
Headquarters GB

Pipeline (1)

Search pipeline →

  1. CLS2901C (human [allogeneic] chondrocyte sheets)

    CellSeed

    Osteoarthritis of the Knee

    phase 3 mab active

    1 trial

Frequently asked questions

What is CellSeed?

CellSeed (E4175F1) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does CellSeed sponsor?

We track 1 ClinicalTrials.gov-linked program for CellSeed, including CLS2901C (human [allogeneic] chondrocyte sheets). Open each program for phase, modality, NCT IDs, and indication details.

Where does CellSeed company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.